EC ever use among women of reproductive age: 1.2% (DHS 2001)
EC knowledge among women of reproductive age: 21.4% (DHS 2001)
Contraceptive Use: 64.1% (DHS 2001, ever use of a modern method among women of reproductive age)
Registered LNG-EC products:
- Anlitin (.75mg) - Available only with prescription
- Anlitin (1.5mg) - Available only with prescription
- PPMS - Available only with prescription
- Pregnon 1.5 - Available only with prescription
- Prikul - Available only with prescription
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Pharmacies, IPPF-affiliated system
Age restrictions for accessing ECPs: No
Legal/regulatory documents in which EC is included: Essential Medicines List
Other relevant information: There is no budget to purchase EC. A product containing ulipristal acetate has been registered but is not yet on the market.
EC distributed via IPPF outlets (<500 in 2012).
In Nicaragua, the lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is doctors, as of 2013. (USAID/DELIVER, Contraceptive Security Indicators, 2013)
In 2013, EC was not procured by the government (JSI/Deliver data).